Recently, the inhibition of histone acetylation readers from the BET family protein is deliberated to have potential in schizophrenia therapy since the BET family inhibitor, JQ1 improves transcriptional abnormalities in the neurones of schizophrenia patients [123]. This evidence concerns the gene DNER and schizophrenia.